Friday, July 10, 2026

Drug profile · INN

omega-3-carboxylic acids

omega-3-carboxylic acids (EPANOVA) is a unknown. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — omega-3-carboxylic acids
US status
approved
Class
Route
ORAL
Patents
0
Programs
1
Data quality
0.84

Quick answer

omega-3-carboxylic acids (EPANOVA) is a unknown. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN omega-3-carboxylic acids
Brand EPANOVA
Mechanism Unknown
Route ORAL
Formulation CAPSULE

Mechanism of action

Unknown

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. ION269-CS1 Phase 1 · IONIS PHARMACEUTICALS · Alzheimer’s Disease in Individuals with Down Syndrome

Frequently asked questions

What is omega-3-carboxylic acids?

omega-3-carboxylic acids (EPANOVA) is a unknown. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for omega-3-carboxylic acids?

EPANOVA is a marketed brand name for omega-3-carboxylic acids. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of omega-3-carboxylic acids?

omega-3-carboxylic acids has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.